EP3716998
A1AT FOR REDUCING RISK OF ONSET OF ACUTE GRAFT VERSUS HOST DISEASE AFTER HEMATOPOEITIC CELL TRANSPLANTATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.11.2018EP published:
10.1.2024EP application number:
18821851.5
EPO information:
European Patent Register
Max expiry date:
29.11.2038
Title in English:
A1AT FOR REDUCING RISK OF ONSET OF ACUTE GRAFT VERSUS HOST DISEASE AFTER HEMATOPOEITIC CELL TRANSPLANTATIONLanguage of the patent:
English
Timeline
Today
30.11.2018EP application
10.1.2024EP Publication
Owner
Name:
CSL Behring LLCAddress:
1020 First Avenue, King of Prussia, PA 19406, US
Inventor
Name:
UKNIS, MarcAddress:
Doylestown, PA 18902, US
Name:
VOIGT, ChristineAddress:
Devon, PA 19333, US
Name:
BAHETI, GautamAddress:
Chester Springs, PA 19425, US
Name:
ROBERTS, JohnAddress:
Exton, PA 19341, US
Priority
Number:
201762593446 PDate:
1.12.2017Country:
US
Number:
201862729376 PDate:
10.9.2018Country:
US
Classification
Categories:
A61K 38/57, A61P 37/06